Effect of teriparatide treatment on endothelial function, glucose metabolism and inflammation markers in patients with postmenopausal osteoporosis

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2265|85|4|556-560

ISSN： 0300-0664

Source： CLINICAL ENDOCRINOLOGY, Vol.85, Iss.4, 2016-10, pp. : 556-560

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Parathyroid hormone (1–84) and teriparatide in the treatment of postmenopausal osteoporosis

By Bogado1 César E   Massari2 Fabio E   Zanchetta3 José R  

Women's Health, Vol. 2, Iss. 3, 2006-05 ,pp. : 447-457

Future Medicine

Access to resources Recommend Favorite

Adrenal effects of teriparatide in the treatment of severe postmenopausal osteoporosis

By Lasco A.   Catalano A.   Morabito N.   Gaudio A.   Basile G.   Trifiletti A.   Atteritano M.  

Osteoporosis International, Vol. 22, Iss. 1, 2011-01 ,pp. : 299-303

Springer Publishing Company

Access to resources Recommend Favorite

The use of teriparatide and PTH(1–84) for the treatment of osteoporosis

By Wagman Rachel   Miller Paul  

Clinical Review in Bone and Mineral Metabolism, Vol. 4, Iss. 4, 2006-12 ,pp. : 277-290

Humana Press, Inc

Access to resources Recommend Favorite

Adherence and persistence in patients with severe osteoporosis treated with teriparatide

By Ziller V.   Zimmermann S.P.   Kalder M.   Ziller M.   Seker-Pektas B.   Hellmeyer L.   Hadji P.  

Current Medical Research and Opinion, Vol. 26, Iss. 3, 2010-03 ,pp. : 675-681

Informa Healthcare

Access to resources Recommend Favorite

Persistence with teriparatide in patients with osteoporosis: the UK experience

By Arden N.   Earl S.   Fisher D.   Cooper C.   Carruthers S.   Goater M.  

Osteoporosis International, Vol. 17, Iss. 11, 2006-11 ,pp. : 1626-1629

Springer Publishing Company

Access to resources Recommend Favorite